CymaBay Therapeutics Inc (DELISTED) (CBAY:DL)
32.48
0.00 (0.00%)
USD |
NASDAQ |
Mar 25, 16:00
CymaBay Therapeutics Total Long Term Debt (Quarterly): 109.17M for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 109.17M |
| September 30, 2023 | 104.09M |
| June 30, 2023 | 99.25M |
| March 31, 2023 | 94.63M |
| December 31, 2022 | 90.23M |
| September 30, 2022 | 86.15M |
| June 30, 2022 | 82.33M |
| March 31, 2022 | 78.68M |
| December 31, 2021 | 50.32M |
| September 30, 2021 | 23.26M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 5.361M |
| December 31, 2017 | 6.098M |
| September 30, 2017 | 6.81M |
| June 30, 2017 | 7.496M |
| March 31, 2017 | 8.159M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2019
109.17M
Maximum
Dec 2023
43.06M
Average
23.26M
Median
Sep 2021
Total Long Term Debt (Quarterly) Benchmarks
| Gilead Sciences Inc | 0.00 |
| Assure Holdings Corp | 13.47M |
| Societal CDMO Inc (DELISTED) | 37.10M |
| AN2 Therapeutics Inc | -- |
| Madrigal Pharmaceuticals Inc | -- |